Athira Pharma's CEO resigns after investigation confirms she altered research during graduate school. vTv Therapeutics named healthcare investor Deepa Prasad its new CEO and president. Opus Genetics snagged a new chief scientific officer and chief operating officer.
/PRNewswire/ ONA Therapeutics ("ONA"), which is focused on the discovery and development of therapeutic biologics targeting lipid metabolism in order to.